CRYOPORT, INC. and U.S. BANK NATIONAL ASSOCIATION as Trustee INDENTURE Dated as of May 26, 2020 3.00% Convertible Senior Notes due 2025Indenture • May 27th, 2020 • Cryoport, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of May 26, 2020, between Cryoport, Inc., a Nevada corporation, as issuer (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 27th, 2020 • Cryoport, Inc. • Pharmaceutical preparations • New York
Cryoport, Inc., a Nevada corporation (the “Company”), proposes to issue and sell to the initial purchasers (collectively, the “Initial Purchasers”) listed in Schedule I to the Purchase Agreement (as defined below), for whom Jefferies LLC and SVB Leerink LLC are acting as representatives, its 3.00% Convertible Senior Notes due 2025 (the “Notes”), upon the terms set forth in the Purchase Agreement by and among the Company and Jefferies LLC and SVB Leerink LLC, dated May 20, 2020 (the “Purchase Agreement”). Upon a conversion of Notes at the option of the holder thereof, the Company will be required to deliver shares of common stock of the Company, $0.001 par value per share (the “Common Stock”). To induce the Initial Purchasers to enter into the Purchase Agreement and to satisfy the Company’s obligations thereunder, the holders of the Notes will have the benefit of this registration rights agreement (this “Agreement”) pursuant to which the Company agrees with the Initial Purchasers for th
